|

Recombinant Human Thyroid Stimulating Hormone Clinical Trials

2 actively recruiting trials

Top Sponsors

  • Nanjing First Hospital, Nanjing Medical University2

Indications

  • Cancer2
  • Recombinant Human Thyroid Stimulating Hormone1
  • Radiotherapy; Complications1
  • Thyroid Stimulating; Hormone, C1
  • DTC - Differentiated Thyroid Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.